G0S2 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, it is possible that ATGL‐mediated SIRT1 activation could be responsible for abolishing G0S2‐mediated apoptosis in scenarios when it is highly expressed (e.g., CP‐CML).